Test

CALAS (Serum)

Other Test Request Name

  • Cryptococcal Antigen Latex Agglutination System (Serum)
  • Cryptococcal Antigen Serum (Qualitative)

Test Composition

Not applicable

Intended Use

Detection of capsular antigens of Cryptococcus neoformans in Serum

Methodology

Latex Agglutintion Test

Laboratory Section

Special Test

Special Instructions/Patient Preparations

 

No patient preparation necessary

Collection/Sample Container

Red or Gold

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

3 mL Serum

Alternative Specimen and Volume Requirement

Not applicable

 Specimen Stability

•   Room Temperature (15-25°C)

Not applicable

 

 

•   Refrigerated Temperature (2-8°C)

3 days

•   Freezer Temperature (-20°C)

Not applicable

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

  • Improperly collected serum sample
  • Quantity not sufficient
  • Improperly labeled specimens
  • Contaminated samples
  • Improper collection container
  • Quantity Not sufficient
  • Exceeded sample stability requirement
  • Hemolyzed specimen

Running Day

Monday to Friday

Cut Off Time

Monday to Friday, 7:00 AM

TAT/Releasing of Results

3 days (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

NEGATIVE

  • Negative  for Cryptococcus neoformans capsular antigen

POSITIVE

  • Positive  for Cryptococcus neoformans capsular antigen

Limitations/Interferences

A negative CALAS test does not preclude diagnosis of cryptococcosis, particularly of only single specimen has been tested and the patient shows symptoms consistent with Cryptococcus.

Although the presence of nonspecific interference can invalidate the CALAS test results, this does not exclude the possibility of cyptococcal infection since cryptococcosis can occur concomitantly with other conditions.

Frequently Asked Questions (FAQs)

Q: What is CALAS?

 A:The Cryptococcal Antigen Latex Agglutination System is a qualitative test for the detection of capsular polysaccharide antigens of Cryptococcus neoformans.

Q: When would I want this test?:

A:When there is a suspected cryptococcosis infection

Q: What will it tell me?

A:Presence of Cryptococcal antigen in the CSF and/or Serum indicates active disease.

Q: Why perform CALAS testing?

A:A simple, sensitive latex test capable of detecting the capsular antigen of Cryptococcus neoformans in CSF and Serum was proven to be superior in sensitivity to the India Ink mount. Clinical studies established the prognostic value of the test and showed it to be a valuable aid in establishing a diagnosis when the culture was negative.

Related Words/Test

Fungal pathogen to infect the central nervous system

 

 

 

 

 

 

 

 

 

 

 

 

 

Test

Calcitonin Assay

Other Test Request Name

• Thyrocalcitonin
• hCT
• TCT

Test Composition

Not applicable

Intended Use

Helps to evaluate thyroid function; Useful in the diagnosis of medullary thyroid carcinoma

Methodology

Enzyme Linked Immunosorbent Immunoassay (ELISA)

Laboratory Section

Special Test

Special Instructions/Patient Preparations

8 hours fasting is preferred.

Collection/Sample Container

Gold or Red Top

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

3 mL Serum

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

Unacceptable

•   Refrigerated Temperature (2-8°C)

24 Hours

•   Freezer Temperature (-20°C)

28 Days

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

• Quantity Not sufficient
• Improperly labeled specimen
• Exceeded sample stability requirement
• Hemolyzed specimen
• Markedly lipemic

Running Day

Friday

Cut Off Time

Thursday, 7:00 AM

TAT/Releasing of Results

After 3 days (excluding Saturdays, Sundays and Holidays)

 

 

 

 

 

 

 

 

 

 

 

 

 

Reference Interval/Result Interpretation

Available upon request

Limitations/Interferences

Basal concentrations of >100 pg/mL have been found to have 100% positive predictive value for medullary thyroid cancer. Lower concentrations may be observed in some patients with clinically apparent medullary thyroid cancer.

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

Human Calcitonin; Thyrocalcitonin, Calcitonin

 

 

Test

Calcium Dialysate

Other Test Request Name

Not applicable

Test Composition

Not applicable

Intended Use

Not applicable

Methodology

Not applicable

Laboratory Section

Special Test

Special Instructions/Patient Preparations

No patient preparation necessary.

Collection/Sample Container

Leak proof clean container

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

2 mL Dialysate

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

7 Days

•   Refrigerated Temperature (2-8°C)

7 Days

•   Freezer Temperature (-20°C)

28 Days

Transport Temperature

Transport specimen at 15°C ~25 °C (room temperature)

Rejection Criteria

 

 

 

 

 

 

 

 

• Quantity Not sufficient
• Exceeded sample stability requirement
• Improperly labeled specimen
• Improper collection tube used

Running Day

Monday to Friday

Cut Off Time

8:00AM

TAT/Releasing of Results

3 days (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Not Applicable

Limitations/Interferences

None specified.

 

 

 

 

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

Dialysate calcium, hemodialysis, calcium balance, vascular calcification, mineral me-
tabolism, calcium-phosphate product.

 

 

Test

Cadmium (ICP-MS) (UNAVAILABILITY OF TUBE)

Other Test Request Name

  • Cadmium
  • Blood Cadmium
  • Blood Cd
  • Cd

Test Composition

Not applicable

Intended Use

Used in a range of different industries - welding, paint and varnish making and fertilizers (super phosphates). Cadmium can cause adverse reactions in people exposed in the course of their work including respiratory, gastrointestinal, hematological and renal problems.

Cadmium is a naturally occurring element that is mined and used in industrial production because of its durability. Excessive cadmium exposure can damage lungs, kidneys, and the digestive tract.

Methodology

Inductively Coupled Plasma - Mass Spectrometry (ICP/MS)

Laboratory Section

Special Test

Special Instructions/Patient Preparations

  • No patiet preparation.
  • Phlebotomist should wear powderless gloves.
  • Request Container to Special test section atleast 2 days prior to collection

Instruction to Phlebotomists:Specimen Collection and  Handling

  1. Wash the collection site with soap and water, followed by an alcohol swab.
  2. Collect the trace metal tube last if other tubes are to be collected from the same site.
  3. Label the complete name of patient on the EDTA Royal blue tube upon extraction.       
  4. After blood extraction, invert EDTA Royal Blue tube 8-10 times to prevent clotting.
  5. Verify and record the name, date of birth, age, gender and employment history of each patient in the Clinical Information.
  6. Note if the patient is pregnant.
  7. After blood collection, do not open specimen tubes at any time prior to shipment. Do not use iodine-containing disinfectants.

Collection/Sample Container

6 mL Royal Blue Tube (Whole Blood) - EDTA

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

2 pcs. of 6mL Royal Tube (Whole Blood) - EDTA

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

14 days

•   Refrigerated Temperature (2-8°C)

14 Days

•   Freezer Temperature (-20°C)

14 Days

Transport Temperature

Transport specimen at 2 – 8 °C (with cold packs)

Rejection Criteria

  • Clotted sample
  • Incorrect sample
  • Insufficient volume or number of tubes
  • Incorrect storage temperature of specimen
  • Exceeded sample stability requirement
  • Improperly labeled specimens

Running Day

Batch Running

Cut Off Time

Monday, 12:00 PM

TAT/Releasing of Results

3 weeks after cut off (excluding Saturdays, Sundays and Holidays)

 

 

 

 

 

 

Reference Interval/Result Interpretation

Available upon request.

Limitations/Interferences

Not Applicable

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

Heavy Metal Poisoning

 

 

 

 

 

 

 

 

Test

Calprotectin (Quali)

Other Test Request Name

  • Fecal Calprotectin (Qualitative)
  • Stool Calprotectin (Qualitative)

Test Composition

Not Applicable

Intended Use

This test offers a simple, highly sensitivity and non-invasive screening assay to determine intestinal inflammatory activity, to monitor treatment response and to predict risk of relapse.

Methodology

Chromatographic immunoassay

Laboratory Section

Clinical Microscopy

 

 

Special Instructions/Patient Preparations

No patient preparation necessary.

Collection/Sample Container

Sterile Leak-proof container

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

20g/Pea size of Stool/Feces

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

7 days

•   Refrigerated Temperature (2-8°C)

7 days

•   Freezer Temperature (-20°C)

(-19°C to -22°C) :6 months

Transport Temperature

Transport sample at:

  • 15°C to 25°C or
  • 2°C to 8°C (with cold packs)

Rejection Criteria

  • Quantity not sufficient (QNS); or less than pea size.
  • Contaminated stool (e.g. with urine or other fluids)
  • Improperly labeled samples
  • Sample that contains formalin and other preservatives and collected with transport media.
  • Exceeded sample stability requirement

Running Day

Monday to Saturday

Cut Off Time

6:00 PM

 

 

TAT/Releasing of Results

ROUTINE

• 4 hours after receipt of specimen/ arrival of messenger
STAT
• After 1½ hours from receipt of specimen/ arrival of messenger
 
Reference Interval/Result Interpretation

 

 

 

 

 

NEGATIVE- There is no human calprotectin presence which might mean neither active gastrointestinal inflammation, no risk of relapse.

Limitations/Interferences

Stool samples with non-steroidal anti-inflammatory drug could show positive result.

Frequently Asked Questions (FAQs)

Q: Why get tested?
  A: To detect inflammation in the intestines; to distinguish between inflammatory bowel disease (IBD) and non-inflammatory bowel conditions; to monitor IBD activity
 Q: When to get tested?
A: When you have bloody or watery diarrhea, abdominal cramps, with or without fever, lasting more than a few days
 Q: When it is ordered?
A: A calprotectin test may be ordered when a person has symptoms that suggest inflammation of the digestive system and when a healthcare practitioner wants to distinguish between IBD and a non-inflammatory bowel condition.
  Testing for calprotectin may be performed when a healthcare practitioner wants to determine whether an endoscopy (colonoscopy or sigmoidoscopy) is likely or less likely to be necessary.
When a person has been diagnosed with IBD, a calprotectin test may be ordered whenever a flare-up is suspected, both to confirm disease activity and to evaluate its severity.
 
Related Words/Test
Lactoferrin, Fecal Immunochemical Test, Fecal Occult Blood Test, Stool Culture, Clostridium difficlile and C. diff toxin testing, Erythrocyte Sedimentation Rate, C-Reactive Protein (CRP)

 

 

 

 

Test

Calprotectin (Quanti)

Other Test Request Name

  • Fecal Calprotectin
  • Stool Calprotectin
  • Fecal Calprotectin Level
Test Composition
Not Applicable
Intended Use
Calprotectin is present in large amount in Granulocytes. Presence in stool reflects bowels inflamation. Quantification may be useful for bowels inflamatory Dieseases diagnosis or follow-up. Calprotectin is a protein released by a type of white blood cell called a neutrophil. When there is inflammation in the gastrointestinal (GI) tract, neutrophils move to the area and release calprotectin, resulting in an increased level in the stool.

This test measures the level of calprotectin in stool as a way to detect inflammation in the intestines.

Methodology

Enzyme Immunoassay

Laboratory Section

Special Test

Special Instructions/Patient Preparations

  • No patient preparation necessary.
  • Ask for Calprotectin Specific Clinical Information Form(R29-INTGB)at Special Test Section atleast one day prior submission of sample.

Collection/Sample Container

Sterile Leak-proof container

 

 

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.
20g/Pea size of Stool/Feces

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

24 Hours

•   Refrigerated Temperature (2-8°C)

7 Days

•   Freezer Temperature (-20°C)

Not Applicable

 

 

Transport Temperature
Transport specimen at 2 – 8 °C (with cold packs)
Rejection Criteria
  • Quantity not sufficient or less than pea size
  • Contaminated stool (e.g) with urine or other fluids)
  • Improperly labeled samples 
  • Sample that contains formalin and other preservatives and collected with transport media.
  • Exceeded sample stability requirement

Running Day

Batch Running

Cut Off Time

Friday, 12:00 PM

TAT/Releasing of Results

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Available upon request

Limitations/Interferences

None Specified

Frequently Asked Questions (FAQs)

Q: Why get tested?

A:To detect inflammation in the intestines; to distinguish between inflammatory bowel disease (IBD) and non-inflammatory bowel conditions; to monitor IBD activity

Q: When to get tested?

A:When you have bloody or watery diarrhea, abdominal cramps, with or without fever, lasting more than a few days

Q: When it is ordered?

A:A calprotectin test may be ordered when a person has symptoms that suggest inflammation of the digestive system and when a healthcare practitioner wants to distinguish between IBD and a non-inflammatory bowel condition.

Signs and symptoms of IBD will vary from person to person and over time. They may include one or more of the following:

  • Bloody or watery diarrhea
  • Abdominal cramps or pain
  • Fever
  • Weight loss
  • Rectal bleeding
  • Weakness

Testing for calprotectin may be performed when a healthcare practitioner wants to determine whether an endoscopy (colonoscopy or sigmoidoscopy) is likely or less likely to be necessary.

When a person has been diagnosed with IBD, a calprotectin test may be ordered whenever a flare-up is suspected, both to confirm disease activity and to evaluate its severity.

Related Words/Test
Lactoferrin, Fecal Immunochemical Test, Fecal Occult Blood Test, Stool Culture, Clostridium difficlile and C. diff toxin testing, Erythrocyte Sedimentation Rate, C-Reactive Protein (CRP)

 

 

 

 

 

 

Test

Campylobacter Fixation

Other Test Request Name

Not applicable

Test Composition

Not applicable

Intended Use

• Campylobacter fetus can cause systemic infection in immunosuppressed patient (e.g those with cirrhosis, blood disorder or aids)and occasionally in pregnant women.
• Diagnosis depends on culturing the bacterium from the blood.

Methodology

Complement Fixation Reaction

Laboratory Section

Special Test

Special Instructions/Patient Preparations

No patient preparation necessary.

Collection/Sample Container

Gold or Red Top

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

3 mL Serum

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

48 Hours

•   Refrigerated Temperature (2-8°C)

4 Days

•   Freezer Temperature (-20°C)

30 Days

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

• Hemolyzed specimen
• Quantity Not sufficient
• Improperly labeled specimen
• Markedly lipemic specimen

Running Day

Batch Running

Cut Off Time

Friday 4:00 PM

TAT/Releasing of Results

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Not Applicable

Limitations/Interferences

None specified

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

Gram-negative bacteria.

Test

Carbamazepine (Tegretol)

Other Test Request Name

  • Tegretol
  • Total Carbamazepine

 Test Composition

Not Applicable

Intended Use

To determine the concentration of carbamazepine in the blood to establish an appropriate dose and maintain a therapeutic level

Methodology

Immunoassay (IA)

Laboratory Section

Special Test

Special Instructions/Patient Preparations

 

 

Levels should be drawn before next oral dose with patient at steady state.

Collection/Sample Container

Red tube (DO NOT USE GOLD TUBE or any other type of tube with gel separator)

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

3 mL Serum

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

Not Applicable

•   Refrigerated Temperature (2-8°C)

 

 

3 Days

•   Freezer Temperature (-20°C)

Not Applicable

 

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

  • Quantity Not sufficient
  • Improperly labeled specimen
  • Exceeded sample stability requirement
  • Hemolyzed specimen
  • Markedly lipemic

Running Day

Monday to Friday

 

 

Cut Off Time

Monday to Friday, 7:00 AM

TAT/Releasing of Results

3 days aftre (excluding Saturdays, Sundays and Holidays

Reference Interval/Result Interpretation

Available upon request

Limitations/Interferences

None Specified.

Frequently Asked Questions (FAQs)

Q: When to get tested?

A:At regular intervals to monitor the drug's level; when indicated to detect low or excessive (potentially toxic) concentrations

Q: What is being tested?

A:Carbamazepine is a drug that is primarily used to treat certain seizure disorders (also called epilepsy) but is also prescribed to stabilize the moods of people with bipolar disease, to ease alcohol withdrawal, and to help alleviate some types of nerve pain. It may be prescribed by itself or in combination with other antiepileptic drugs. This test measures the level of carbamazepine in the blood.

Carbamazepine levels are monitored because the drug must be maintained within a narrow therapeutic range. If the level is too low, the drug may not be effective and the person may experience a recurrence of symptoms (i.e., seizures, mania, or pain); if the level is too high, the person may experience toxic side effects. Maintaining a therapeutic level of this drug can be a challenge to achieve for several different reasons:

  • Oral doses of carbamazepine are absorbed in the gastrointestinal tract at widely variable rates. 
  • Since carbamazepine is metabolized by the liver, anything that affects liver function can affect blood levels of the drug. 
  • Upon a long-term administration, carbamazepine induces its own metabolism.
  • Much of the drug is bound to plasma protein, but it is the free portion of the drug that is active. Conditions that affect protein binding of the drug may affect therapeutic effectiveness. This may occur when someone has low blood albumin, kidney failure, or when they are very young (newborn) or elderly. 
  • The metabolite of carbamazepine, carbamazepine-10,11-epoxide, is also therapeutically active and contributes to the overall effect of the medication. 
  • Several drugs, if taken in conjunction with carbamazepine, may interact or affect its metabolism and blood levels.

Dosages of carbamazepine must be adjusted carefully in order to reach a steady concentration in the blood. The actual amount of drug required to reach this steady state will vary from person to person and may change over time.

Carbamazepine is usually monitored long-term because it is prescribed to treat the chronic conditions epilepsy, bipolar disorder, trigeminal neuralgia, and nerve pain from diabetes.

Epilepsy affects the brain's ability to transmit electrical impulses and to regulate nerve activity. During a seizure, a person may experience changes in consciousness, alterations in sight, smell, and taste, and may experience convulsions. The frequency of seizures varies from a single episode, to occasional seizures, to recurrent seizures. Carbamazepine is prescribed to help prevent specific types of recurrent seizures.

Bipolar disorder is a mental condition that is characterized by cycles of depression and mania that may last for days, weeks, months, or years. During a depressive episode, those affected may feel sad, hopeless, worthless, and have thoughts of suicide. During a manic episode, those affected may be euphoric, irritable, use poor judgment, and participate in risky behaviors. Carbamazepine is prescribed to help even out the moods of the person with bipolar disorder, especially mania.

Trigeminal neuralgia, a condition associated with facial nerve pain and muscle spasms, and paroxysmal choreoathetosis, a movement disorder that causes involuntary movements of the limbs, trunk, and facial muscles, are also sometimes treated with carbamazepine. So is diabetic peripheral neuropathic pain, which affects the functionality, mood, and sleep patterns of approximately 10-20% of people with diabetes mellitus. (For more on this, see the Neuropathy article.)

Q: How it is used?

A:The carbamazepine test is used to measure and monitor the amount of carbamazepine in the blood to determine whether the level of drug is within the therapeutic range. Carbamazepine is primarily used to treat certain seizure disorders (also called epilepsy) but is also prescribed to stabilize the moods of people with bipolar disease, to ease alcohol withdrawal, and to help alleviate some types of nerve pain.

Initially, the test may be used to establish the appropriate dose for an individual. Depending on the results of the blood test, the dose of drug may be adjusted up or down until the blood level reaches the therapeutic range. Subsequent tests are then used to ensure that the level remains in the therapeutic range. If a person's health changes or if, for example, they begin taking other drugs, the test may be used to determine whether an adjustment to the prescribed dose is necessary.

A healthcare practitioner may use a carbamazepine test to help evaluate someone who is experiencing side effects or adverse reactions or a recurrence of symptoms.

A routine carbamazepine test measures total carbamazepine, both protein-bound and free portions of the drug. Sometimes a test to measure free carbamazepine or the biologically active metabolite, carbamazepine-10,11-epoxide, is ordered along with the total carbamazepine test to evaluate their contribution to a person's therapy.

Q: When it is ordered?  

A:Carbamazepine tests are ordered frequently at first, then at regular intervals and as needed to ensure that therapeutic blood concentrations are maintained.

Additional total carbamazepine tests may be ordered if dosages of the drug are changed or if the treated person starts or stops taking additional medications to judge their effect, if any, on the carbamazepine level. Once blood concentrations of carbamazepine have stabilized, concentrations are monitored at regular intervals to ensure that they remain within therapeutic range.

The carbamazepine test may be ordered when a person does not appear to be responding to therapy and has a recurrence of symptoms such as seizure, nerve pain, or bipolar mood swings. The blood level may not be high enough, the person may not be taking the medication regularly, or the drug may be ineffective for that person.

Carbamazepine tests may also be ordered when a person experiences a troublesome level of side effects and/or develops complications. Side effects that may be seen at any dose but that are related to higher concentrations include:

  • Dizziness
  • Uncoordinated movement
  • Sleepiness
  • Blurred or double vision
  • Involuntary back and forth movement of the eyeball

Other side effects may include:

  • Red, itchy rash
  • Nausea
  • Diarrhea
  • Constipation
  • Headache
  • Confusion

A healthcare practitioner should be contacted immediately if someone has serious side effects, including:

  • Pale skin, rapid heart rate, trouble concentrating
  • Fever, chills, or sore throat
  • Mouth and throat ulcers
  • Easy bruising or bleeding
  • Severe tingling, numbness, pain, muscle weakness
  • Confusion, agitation, vision problems, or hallucinations
  • Shortness of breath
  • Swelling of the ankles or feet
  • Urinating less than usual
  • Yellowing of the skin or eyes
  • Severe skin reaction

Carbamazepine can also sometimes cause liver dysfunction, low sodium levels, a decrease in white blood cells, or an increase in eosinophils (a type of white blood cell). In some cases, the severity of side effects may necessitate use of a different anti-seizure, bipolar, or nerve pain medication.

A free carbamazepine test and/or a carbamazepine-10,11-epoxide test may also be ordered along with the total carbamazepine test when a healthcare practitioner wants to evaluate the contribution of the free drug and/or its metabolite to drug therapy. The healthcare practitioner may choose to do so when the result from a total carbamazepine test is within the therapeutic range but the treated person is experiencing side effects. Sometimes results are evaluated as a percentage of free to total carbamazepine.

 Related Words/Test

Valproic Acid Phenytoin Therapeutic Drug Monitoring Emergency and Overdose Drug Testing Pharmacogenetic Tests.

 

 

 

 

 

 

Test

Carbo. Def. Transferrin

Other Test Request Name

  • Carbohydrate Deficient Transferrin
  • CDT
  • Decarboxytransferrin
  • Sialic acid-deficient transferrin
  • Asialotransferrin
  • CD Test

Test Composition

Not applicable

Intended Use

This test is used to detect chronic alcoholism.

The consumption of 50 to 80 grams of alcohol every day for one week induces a rise in the level of carboxy-deficient transferrin (CDT) (specificity 98%, sensitivity 80%). After withdrawal, the serum CDT concentration drops off again with a half-life of 14 to 17 days.

Methodology

Capillary Electrophoresis

Laboratory Section

Special Test

Special Instructions/Patient Preparations

No patient preparation necessary.

Collection/Sample Container

Gold or Red Top

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

3 mL Serum

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

 

 

 

 

 

 

 

24 Hours

•   Refrigerated Temperature (2-8°C)

7 Days

•   Freezer Temperature (-20°C)

28 Days

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

  • Hemolyzed specimen
  • Quantity Not sufficient
  • Improperly labeled specimen
  • Markedly lipemic specimen

Running Day

Batch running

Cut Off Time

Friday, 4:00 PM

TAT/Releasing of Results

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Available upon request

Limitations/Interferences

None specified

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

detect heavy ethanol consumption

 

 

 

 

 

 

 

 

Test

COBALT (UNAVAILABILITY OF TUBE)

Other Test Request Name

Not Applicable

Test Composition

Not Applicable

Intended Use

Cobalt is part of our diet. Approximately 85% of absorbed cobalt is excreted in the urine and the remainder eliminated in stool. Toxicity may occur in select industrial environments. Cobalt is not mined in the United States so primary supplies are imported.

Methodology

Inductively Coupled Plasma/Mass Spectrometry (ICP/MS)

Laboratory Section

Special test

Special Instructions/Patient Preparations

  • Patient should refrain from taking mineral supplements, vitamin B12 or vitamin B complex 3 days prior to specimen collection
  • Blood sample will be drawn every Monday - Wednesday from until 3pm only.
  • Request Container to Special test section atleast 2 days prior to collection

Instruction to Phlebotomists:Specimen Collection and  Handling

  1. Wash the collection site with soap and water, followed by an alcohol swab.
  2. Collect the trace metal tube last if other tubes are to be collected from the same site.
  3. Label the complete name of patient on the EDTA Royal blue tube upon extraction.       
  4. After blood extraction, invert EDTA Royal Blue tube 8-10 times to prevent clotting.
  5. Verify and record the name, date of birth, age, gender and employment history of each patient in the Clinical Information.
  6. Note if the patient is pregnant.
  7. After blood collection, do not open specimen tubes at any time prior to shipment. Do not use iodine-containing disinfectants.

Collection/Sample Container

6 mL Royal Blue Tube (Whole Blood) - EDTA

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

2 pcs. of 6mL Royal Tube (Whole Blood) - EDTA

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

48 hours

•   Refrigerated Temperature (2-8°C)

5 days

 

 

•   Freezer Temperature (-20°C)

Unacceptable

Transport Temperature

Transport specimen at 2 – 8 °C (with cold packs)

Rejection Criteria

Not Applicable

Running Day

Batch Running

Cut Off Time

Monday, 12:00 PM

TAT/Releasing of Results

2 weeks after cut off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Not Applicable

Limitations/Interferences

Not Applicable

Frequently Asked Questions (FAQs)

Not Applicable

Related Words/Test

Not Applicablex

 

 

 

 

 

 

 

 

 

 

 

Test

Cocaine

Other Test Request Name

• Coke
• Crack
• Gold dust
• Stardust
• White girl
• Speed balls

Test Composition

Not applicable

Intended Use

Used as a screening test for qualitative detection of cocaine in urine.

Methodology

Lateral Flow Immunochromatography (Competitive Binding)

Laboratory Section

Drug Test

Special Instructions/Patient Preparations

No patient preparation necessary

Collection/Sample Container

60-mL clean, screw cap, polyethylene container

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

60 mL urine

Alternative Specimen and Volume Requirement

Not applicable

Specimen Stability

•   Room Temperature (15-25°C)

Not specified

•   Refrigerated Temperature (2-8°C)

48 Hours

•   Freezer Temperature (-20°C)

Not specified

Transport Temperature

Not applicable

Rejection Criteria

Incompatibility of the ID number on the specimen received by the laboratory with the number on the CCF.
• Absence of ID number on the specimen
• No printed Authorized Specimen Collector’s name and signature on the CCF.
• Broken or tampered seal on the specimen container
• Insufficient quantity of specimen, below 60 mL for single collection; below 30 mL for spilt collection

Running Day

Daily

Cut Off Time

Monday to Saturday
• 6:00 PM
Sunday
• 3:00 PM

TAT/Releasing of Results

ROUTINE
• 3 hours after receipt of specimen/ arrival of messenger
STAT
• After 1½ hours from receipt of specimen/ arrival of messenger

Reference Interval/Result Interpretation

Not applicable

Limitations/Interferences

Other drugs with the same structure with the abused drugs
• Cross-reactant chemicals
• Bleach or alum

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

Recreational drug

Test

Chlamydia Antigen (Swab)

Other Test Request Name

  • Chlamydia trachomatis Antigen (Swab)
  • Chlamydia trachomatis Antigen Rapid Test (Swab)

Test Composition

Not applicable

Intended Use

Qualitative presumptive detection of Chlamydia trachomatis in cervical swab specimens

Methodology

Immunochromatography

Laboratory Section

Bacteriology

Special Instructions/Patient Preparations

DOCUMENTATION REQUIREMENT:

Microbiology Request Form (completely filled out)

COLLECTION KIT SUPPLY REQUISTION:

Use only Dacron or Rayon tipped sterile swabs. Collection kit is provided by Hi-Precision Diagnostics.

  • HPD Branches – request supply at SAP Program.
  • Send-in Clients – request collection kit from HPD.

CERVICAL SAMPLE COLLECTION INSTRUCTIONS:

  1. Remove excess mucus from endocervical area with cotton.
  2. Insert swab into the endocervical canal, until tip is not visible.
  3. Rotate the swab for 15-20 seconds.
  4. Place swab in a dry sterile container or dry transport tube

URETHRAL SAMPLE COLLECTION INSTRUCTIONS:

  1. Instruct patient not to urinate at least one hour prior to collection of urethral swab.
  2. Standard wire-shafted fiber-tipped swabs or cytology brushes should be used.
  3. Insert swab into the urethra about 2-4 cm, rotate for 3-5 seconds
  4. Place swab in a dry sterile container or dry transport tube

Collection/Sample Container

1 (pc) Dacron or Rayon tipped sterile swab collected in a dry sterile container or dry transport tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

Female: Cervical discharge

Male: Urethral discharge

Alternative Specimen and Volume Requirement

Male:Urine (See Chlamydia Antigen Urine for details)

Female:No alternative sample for Female Patients

Specimen Stability

•   Room Temperature (15-25°C)

Room temperature (20-25°C): 24 hours

•   Refrigerated Temperature (2-8°C)

Refrigerated temperature (2-8°C): 7 days

•   Freezer Temperature (-20°C)

Freezer temperature (-20°C):  6 months

Transport Temperature

Place samples in sterile container or transport tube and store at refrigerated temperature (with cold ice packs)

Rejection Criteria

  • Improperly collected sample
  • Improperly labelled specimens
  • Sample contaminated or soaked with NSS
  • Unsterile collection container; container not sealed
  • Ordinary cotton swabs for Cervical and Urethral samples

Running Day

Daily

Cut Off Time

8:00 PM

TAT/Releasing of Results

ROUTINE: 4 hours after receipt of specimen/ arrival of messenger

STAT:2  hours after receipt of specimen/ arrival of messenger

Reference Interval/Result Interpretation

NEGATIVE

  • Negative for Chlamydia Antigen

POSITIVE

  • Positive for Chlamydia Antigen

Limitations/Interferences

  1. Chlamydia Rapid Test is for in vitro diagnostic use and should be used for the qualitative detection of Chlamydia trachomatis only.
  2. Chlamydia Rapid test does not specifically differentiate C. trachomatis, C. pneumonia, C. psittaci.
  3. Detection of Chlamydia is dependent on the number of organism present in the specimen. This may be affected by specimen collection methods and patient factors such as age, history of STD, and presence of symptoms.
  4. The minimum detection of this test may vary according to serovar.

Frequently Asked Questions (FAQs)

Q: What is Chlamydia trachomatis Antigen Rapid Test?

A:It is a rapid visual immunoassay for the qualitative presumptive detection of Chlamydia trachomatis in female cervical swab and male urethral swab (or urine for male).

Q: When would I want this test?

A:When there is a suspected Chlamydia trachomatis infection.

Q: What will it tell me?

A:Presence of Chlamydia trachomatis antigen in swabs and urine (for male)

Q: Why perform Chlamydia trachomatis Antigen Rapid testing?

A: Traditional culture method is the most sensitive but requires long time (2-3 days) for testing and not routinely available in most institutions. Chlamydia trachomatis Antigen rapid test has shorter time required for testing compared to culture methods and can quickly aid to the diagnosis of Chlamydia infection.

Related Words/Test

Not Applicable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test

Chlamydia Antigen (Urine)

Other Test Request Name

  • Chlamydia trachomatis Antigen (Urine)
  • Chlamydia trachomatis Antigen Rapid Test (Urine)

Test Composition

Not applicable

Intended Use

Qualitative presumptive detection of Chlamydia trachomatis in urine

Methodology

Immunochromatography

Laboratory Section

Bacteriology

Special Instructions/Patient Preparations

DOCUMENTATION REQUIREMENT:

Microbiology Request Form (completely filled out)

URINE SAMPLE COLLECTION INSTRUCTIONS:

  1. Instruct patient not to urinate at least 1 hour prior to collection.
  2. Collect into a dry sterile container

Collection/Sample Container

Dry sterile container

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

Male:30 ml Urine

Alternative Specimen and Volume Requirement

Urethral Swab (See Chlamydia Antigen Swab)

Specimen Stability

•   Room Temperature (15-25°C

Room temperature (20-25°C): 6 hours

 

 

 

•   Refrigerated Temperature (2-8°C)

Refrigerated temperature (2-8°C): 5 days

•   Freezer Temperature (-20°C)

Freezer temperature (-20°C):  Not applicable

Transport Temperature

Place samples in sterile container or transport tube and store at refrigerated temperature (with cold ice packs)

Rejection Criteria

  • Quantity not sufficient
  • Improperly collected sample
  • Improperly labelled specimens
  • Samples contaminated with feces
  • Unsterile collection container; container not sealed

Running Day

Daily

Cut Off Time

8:00 PM

TAT/Releasing of Results

ROUTINE:

  • 4 hours after receipt of specimen/ arrival of messenger.

STAT:

  • 2  hours after receipt of specimen/ arrival of messenger

Reference Interval/Result Interpretation

NEGATIVE

  • Negative for Chlamydia Antigen

POSITIVE

  • Negative for Chlamydia Antigen

Limitations/Interferences

1.      Chlamydia Rapid Test is for in vitro diagnostic use and should be used for the qualitative detection of Chlamydia trachomatis only.

2.      Chlamydia Rapid test does not specifically differentiate C. trachomatis, C. pneumonia, C. psittaci.

3.      Detection of Chlamydia is dependent on the number of organism present in the specimen. This may be affected by specimen collection methods and patient factors such as age, history of STD, and presence of symptoms.

4.      The minimum detection of this test may vary according to serovar.

 

Frequently Asked Questions (FAQs)

Q: What is Chlamydia trachomatis Antigen Rapid Test?

A:It is a rapid visual immunoassay for the qualitative presumptive detection of Chlamydia trachomatis in female cervical swab and male urethral swab (or urine for male).

Q: When would I want this test?

A:When there is a suspected Chlamydia trachomatis infection.

Q: What will it tell me?

A:Presence of Chlamydia trachomatis antigen in swabs and urine (for male)

Q: Why perform Chlamydia trachomatis Antigen Rapid testing?

A: Traditional culture method is the most sensitive but requires long time (2-3 days) for testing and not routinely available in most institutions. Chlamydia trachomatis Antigen rapid test has shorter time required for testing compared to culture methods and can quickly aid to the diagnosis of Chlamydia infection.

Related Words/Test

Not Applicable

 

 

 

 

 

 

 

 

 

 

 

 

 

Test

Chlamydia psittaci (IF)

Other Test Request Name

  • Psittacosis
  • Ornithosis
  • Chlamydia psittaci

Test Composition

Not applicable

Intended Use

Responsible for anthropozoonosis of variable clinical expression. Psittacosis, transmitted by psittacidae, is a severe infection inducing a malignant septicaemic infectious syndrome. Ornithosis, transmitted by pigeons and possibly other birds or domestic mammals, is a generally benign atypical pneumopathy. This is basically a serological diagnostic, by demonstration of a seroconversion or observation of an initially high rated level of IgG.

Methodology

Indirect immunofluorescence

Laboratory Section

Special Test

Special Instructions/Patient Preparations

No patient preparation necessary.

Collection/Sample Container

Red or Gold Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.

3 mL Serum

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

3 Days

•   Refrigerated Temperature (2-8°C)

7 Days

•   Freezer Temperature (-20°C)

28 Days

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

Hemolyzed specimen
• Quantity Not sufficient
• Markedly lipemic sample
• Improperly labeled specimen

Running Day

Batch running

Cut Off Time

Friday 4:00 PM

TAT/Releasing of Results

2 weeks after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Available upon request

Limitations/Interferences

None specified

Frequently Asked Questions (FAQs)

Not applicable

Related Words/Test

Lethal intracellular bacterial species

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Test

Chlamydia Trachomatis (PCR)

Other Test Request Name

Chlamydia Trachomatis Detection by Molecular Amplification 

Test Composition

Not Applicable

Intended Use

Bacterium which only infects the eyes and the genitalia. It usually causes trachoma, inclusion conjunctivitis or sexually transmitted disease. Lymphogranuloma venereum remains an exotic infection. "Non-specific" urethritis and cervicitis can be relatively asymptomatic and lead to spread of the infection and ultimately tubular damage and infertility in women or epididymitis and prostatitis in men. A role for C. trachomatis has been suggested in some forms of perihepatitis and in Reiter's syndrome. Infants born to infected mothers may present with post-natal conjunctivitis (which is resistant to silver nitrate treatment) and severe pneumonia. The bacterium can often be directly detected in conjunctival or genital smears. Nucleic acid-based techniques (e.g. PCR) are sensitive, specific and do not necessitate invasive procedures (a urine specimen or a vulvar smear is suitable). Culture takes much longer and requires a urethral, cervical or conjunctival smear and perfect transport conditions. Seroconversion and the presence of IgM are demonstrated in cases of recent primary infection and in infected newborns. Apart from these situations, the presence of IgG indicates contact with the bacterium, which cannot be dated, in that these antibodies persist for a long time and are only influenced by an effective treatment at a late stage. The presence of specific IgA may be of interest in cases of active infection. Note the existence of serological cross-reactions between the different Chamydia species.

Methodology

Molecular biology

Laboratory Section

Special test

Special Instructions/Patient Preparations

  • Urine Specimen Transport Tube must be requested 2 days prior to collection. (Provided by Special Test Section)
  • Urine samples must be transfered into the Urine Transport Tube within one hour of sample collection.

 

Procedure of Collection:

  1. Ask the patient to provide a first catch urine sample approximately 10-15ml into a sterile urine container.
  2. Remove the lid of the Urine Specimen Transport Tube and transfer 2ml of urine using the disposable pipette provided
  3. The correct volume of urine has been added when the fluid level is between the black fill lines on the Urine Specimen Transport Tube.
  4. Tightly close the lid of the Urine Specimen Transport Tube. 
  5. Put labels and barcode.
  6. Send samples to mainlab both Urine Specimen Transport Tube and the sterile urine container collected from patient.

Collection/Sample Container

Sterile Container and Urine Specimen Transport Tube(tube provided by Special Test Section)

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation

10-15 mL Urine (Random Urine)

Alternative Specimen and Volume Requirement

Not Applicable

Specimen Stability

•   Room Temperature (15-25°C)

7 Days

•   Refrigerated Temperature (2-8°C)

7 Days

•   Freezer Temperature (-20°C)

Not Applicable

Transport Temperature

Transport specimen at 2°C - 8°C (with cold packs)

Rejection Criteria

  • Exceed sample stability requirement
  • Incorrect collection container used
  • Improperly labeled specimen

Running Day

Batch Running

Cut Off Time

Friday, 4:00 pm

TAT/Releasing of Results2 Weeks after cut-off (Excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation

Available upon request

Limitations/Interferences

None Specified.

Frequently Asked Questions (FAQs)

Q: Why get tested?

A:To screen for and diagnose a chlamydia infection.

Q: When to get tested?

A:For women, yearly screening is recommended if you are sexually active and younger than age 25 or older and at increased risk for this sexually transmitted disease (STD); when you are pregnant or considering preganancy.For men, yearly screening is recommended if you are a man who has sex with men When you have symptoms of this STD, such as pain during urination, vaginal discharge and abdominal pain (for women) or unusual discgharge from the peni, pain on urination or painful, swollen testicles (for men).

When a newborn has conjuctivitis.

Related Words/Test

Gonnorrhea Testing, HIV Antibody, Syphilis Tests,Herpes Testing, HPV Test, Trichomonas Testing